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be insufﬁcient to identify Treg in humans. To determine whether
the ICOS T-cell populations which were modulated with ECP
treatment were functionally Treg, we isolated CD4CD25
ICOS and CD4CD25 ICOS- cells from patients with
cGVHD before and after ECP therapy and demonstrated that the
CD4CD25ICOS cells functioned as suppressors in an MLR
reaction, suggesting that these cells represent Treg cells. We
conclude that these ICOSCD25CD4 T-helper cells may rep-
resent, in part, immunoregulatory T-cells implicated in the induc-
tion of tolerance. We propose that the mechanism of action of
ECP in cGVHD involves both modulation of DC to induce mat-
uration markers, including possibly the ligand for ICOS (B7H2), as
well as the induction of ICOS expressing CD25 immunoregula-
tory T-helper cells.
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DEFECTIVE POPULATIONS OF REGULATORY T CELLS CORRELATE
WITH THE OCCURRENCE OF CHRONIC GRAFT VERSUS HOST DISEASE
AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
Zorn, E., Floyd, B., Lee, S.J., Soiffer, R.J., Antin, J.H., Ritz, J.
Dana-Farber Cancer Institute, Boston, MA
Chronic-Graft-Versus-Host-Disease (cGVHD) is a major com-
plication of hematopoietic stem cell transplantation (HSCT). Al-
though the precise etiology of cGVHD is still unknown, recent
evidence suggests that defects in regulation of donor immunity
play an important role in this disease. CD4CD25 regulatory T
cells (T-regs) are critical elements of immune regulation in normal
individuals. T-regs develop in the thymus and reach the periphery
where they inhibit autoreactive effector T cells. After HSCT the
number of recipient hematopoietic cells, including T-regs, are
severely reduced. In adults, residual thymic function is also affected
after transplantation, limiting the reconstitution of CD4CD25
T cells in the periphery. We hypothesized that the occurrence of
cGVHD correlates with a quantitative and qualitative defect in
T-regs reﬂecting a global deregulation of the immune system.
PBMC collected from 29 patients with mild, moderate or severe
cGVHD (group-A), 7 patients who had cGVHD but had resolved
their disease (group-B), and 15 healthy controls (group-C) were
analyzed by complementary methods to assess circulating popula-
tions of T-regs. 1) Percentages of circulating CD4CD25 cells
in total PBL were compared for the 3 groups. 2) Expression of the
T-reg speciﬁc transcription factor foxP3 was assessed by quantita-
tive PCR and reported as a function of CD3 cells. 3) Functional
activity of CD25 T-regs was measured using an in vitro assay
based on the modulation of viral antigen reactive CD8 T cells.
Phenotypic and molecular results were consistent and showed a
signiﬁcant decrease in circulating CD4CD25 cells as well as
lower expression of foxP3 in group A compared to control group
C. Patients with resolved cGVHD (group B) were indistinguish-
able from healthy donors either phenotypically or using the mo-
lecular assay, suggesting that they had recovered normal levels of
T-regs. In functional assays, using samples from cGVHD patients
(group A), a correlation was found between the quantitative assess-
ment of T-regs and their capacity to inhibit class-I anti-viral
effector T cells. In conclusion, these experiments strongly support
our hypothesis that a defect in CD4CD25 T cell populations
correlates with cGVHD and establishes a framework for the de-
velopment of new therapeutic interventions for this disease.
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TNFa is a primary effector molecule in the pathophysiology of
Idiopathic Pneumonia Syndrome (IPS), a frequently fatal compli-
cation after allogeneic (allo) stem cell transplantation (SCT). How-
ever, the contribution of host versus donor derived TNFa to the
development of IPS remains to be determined. Using a lethally
irradiated B6B6D2F1 mouse SCT model, we found that signif-
icant lung injury was present by week 5 after allo SCT compared
to syn controls. Both pulmonary macrophages and T cells were
completely of donor origin at this time. Furthermore, numbers of
TNFa secreting CD4 and CD8 T cells were signiﬁcantly increased
in the BAL ﬂuid (BALF) after allo SCT (CD8: 154 15 vs 2 0.2,
CD4: 76 7 vs 29 2 (x1000)) and pulmonary macrophages from
allo mice secreted signiﬁcantly more TNFa when restimulated
with LPS in vitro (357  127 vs 136  31 pg/ml). We therefore
hypothesized that donor cell-derived TNFa is important to devel-
opment of IPS and tested this by using B6 wild type (wt) or B6
TNFa-/- mice as allo SCT donors: TNFa-/- SCT resulted in
signiﬁcantly reduced lung injury(1.2  0.3 vs 4.1  0.7) and BALF
TNF levels (4.8  3.7 vs 67.4  27.0 pg/ml) compared to wt
controls. These ﬁndings were conﬁrmed in two other allo SCT
systems wherein donor and host differ either at class I or II MHC
only (B6bm1 or B6bm12). In addition, lung injury did not
differ between groups when B6TNFa-/- mice were used as recip-
ients in the bm1B6 system. To determine the contribution of
donor accessory (bone marrow) cell- versus T cell-derived TNFa,
we completed mixing experiments in the B6F1 system wherein
wt or TNFa-/- bone marrow (BM) was supplemented with either
wt or TNFa-/- T cells and found that TNFa from both cellular
sources contributes to IPS. Interestingly, the absence of TNFa
from donor T cells alone was sufﬁcient to signiﬁcantly reduce
levels of the inﬂammatory chemokines MIG, RANTES, MIP-1a,
MCP-1 in the lung by week 2 after SCT. Decreased chemokine
expression directly correlated with the recruitment of inﬂamma-
tory cells to the lung; the severity of IPS was completely abrogated
after allo SCT with wt BM and TNFa-/- T cells (syn: 1.1  0.4;
allo contrl: 4.4  0.6; TNFa-/- T: 2.2  0.9). In conclusion, our
data demonstrate that donor derived TNFa is critical to the de-
velopment of IPS and reveal thus far an unrecognized role for T
cell derived TNFa in the regulation of pulmonary chemokine
expression and the subsequent recruitment of donor effector cells
to the lung after allo SCT.
38
SELECTIVE DEPLETION OF T CELL CLONES RESPONSIBLE FOR GVHD
IN A MURINE MODEL
Kappel, B.J., Eng, J.M., Pinilla-Ibarz, J., van den Brink, M.M.R.M.,
Scheinberg, D.A. Memorial Sloan-Kettering Cancer Center, New York,
NY
Graft-versus-host-disease (GVHD), the single most important
complication post allogeneic bone marrow transplantation (BMT),
arises from donor T cell anti-host activity due to mismatches in
major and/or minor histocompatability complexes (MHC and/or
mHAg). Upon encountering a foreign antigen donor T cells un-
dergo antigen speciﬁc clonal expansion, greatly increasing the
number of donor anti-host T cells in circulation. Current therapies
for GVHD include complete non-speciﬁc T cell depletion of bone
marrow (TCD-BM) prior to BMT or immunosuppression post
BMT. However, the use of peptide speciﬁc MHC tetramers allows
for detection of these antigen speciﬁc alloreactive T cell clones.
We hypothesize that speciﬁc targeting and deletion of these T cells
responsible for anti-host activity could prove to be an effective
immunotherapy for the elimination of GVHD.
We have chosen as a murine model of study C57BL/6 (B6) 3
BALB.B, an H2Kb MHC-matched BMT model with one de-
scribed immunodominant mHAg mismatch. This mismatch occurs
at the H60 locus and foreign CD8 T cell receptors recognize a
peptide octamer known as the LYL8 epitope. We propose to show
that the antigen speciﬁc T cells are present, functional, capable of
causing GVHD and removable from the larger population of T
cells. Using phycoerythrin (PE) labeled LYL8 tetramers we iden-
tiﬁed the expanding population of speciﬁc B6 anti-BALB.B T cells
within the spleens of B6 mice immunized with irradiated BALB.B
splenocytes. We then characterized the proliferative and functional
ability of these T cells with mixed lymphocyte reactions and 
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